4min chapter

Breakpoints cover image

#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials

Breakpoints

CHAPTER

Hiv Aids

The first one is looking at single dose liposomal amphitheresin B in the treatment of disseminated histoplasmosis. The phase two trial that's based on this is enrolling right now. All patients got itra conazole capsules 400 milligrams a day. And I see I know we all have feelings about itra Conazole capsule. So we'll hold our peanut gallery comments, but everybody got itraconazole capsules for I can't I can't hold my peanut gallery. Go for it! You're okay. But if you only have capsules, then of course, treat your patient. If they had TB and Rifampa was going to

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode